{"gene":"HNRNPL","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2013,"finding":"hnRNPL binds to the lncRNA THRIL (linc1992) and the THRIL-hnRNPL complex regulates transcription of the TNFα gene by binding to its promoter in THP1 macrophages.","method":"RNA immunoprecipitation, RNA pulldown, ChIP, lentiviral knockdown with transcriptome analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal RIP, promoter ChIP, and KD with transcriptome readout, multiple orthogonal methods in a single rigorous study","pmids":["24371310"],"is_preprint":false},{"year":2002,"finding":"hnRNP-L and APE1 form a protein complex that binds the nCaRE-B2 repressor element in the APE1 promoter, and the APE1–hnRNP-L protein–protein interaction does not require the nCaRE-B2 DNA element, identifying a novel transcriptional regulatory role for hnRNP-L.","method":"Electrophoretic mobility shift assay, UV cross-linking, co-immunoprecipitation, pulldown assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and EMSA in a single lab with two orthogonal methods","pmids":["11809897"],"is_preprint":false},{"year":2012,"finding":"hnRNPL binds LINE-1 ORF2 IRES RNA (confirmed by RNA affinity chromatography) and functions as a negative regulator of L1 retrotransposition; hnRNPL knockdown dramatically increased L1 retrotransposition as well as L1 RNA and ORF1 protein levels.","method":"RNA affinity chromatography, siRNA knockdown, L1 retrotransposition reporter assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical binding assay combined with functional retrotransposition assay and protein/RNA abundance measurement; multiple orthogonal readouts in one study","pmids":["23161687"],"is_preprint":false},{"year":2014,"finding":"hnRNPL interacts with P-TEFb components CDK9, CCNT2, HEXIM1, and the 7SK RNA; hnRNPL knockdown reduces transcripts sensitive to the P-TEFb inhibitor flavopiridol and disrupts the association of 7SK RNA with Aire-containing complexes, indicating hnRNPL promotes RNA polymerase II elongation by facilitating delivery of inactive P-TEFb to Aire.","method":"Genome-scale shRNA screen, co-immunoprecipitation with P-TEFb components, flavopiridol-sensitivity assay, lentiviral KD mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — shRNA screen validated by co-IP, pharmacological inhibition, and in vivo KD; multiple orthogonal methods replicated on endogenous and transfected targets","pmids":["24434558"],"is_preprint":false},{"year":2016,"finding":"HNRNPL acts as a structural adaptor in the Sam68 nuclear body (SNB), joining two distinct RNase-sensitive substructures (the DBC1 body substructure and the Sam68 substructure) through interactions of two sets of RNA recognition motifs (RRMs) with putative architectural RNAs in each substructure.","method":"Fluorescent cDNA screen of 32,651 clones for RNase-sensitive nuclear foci, RNase treatment, siRNA knockdown of each SNB protein, confocal microscopy","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — large-scale unbiased screen followed by RNase sensitivity assays and systematic individual KD with imaging; multiple orthogonal methods in one study","pmids":["27377249"],"is_preprint":false},{"year":2019,"finding":"The seRNA-1 enhancer RNA interacts with hnRNPL via a CAAA tract; disrupting seRNA-1-hnRNPL interaction reduces RNA Pol II and H3K36me3 deposition at the myoglobin (Mb) locus and attenuates its transcription during myogenic differentiation. Transcriptome-wide analysis shows hnRNPL association with eRNAs is a general phenomenon.","method":"RNA immunoprecipitation, ChIRP, ChIP for Pol II and H3K36me3, in vitro and in vivo loss-of-function","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal RIP/ChIRP, ChIP readout, in vivo validation, and transcriptome-wide HNRNPL binding data; multiple orthogonal methods","pmids":["31857580"],"is_preprint":false},{"year":2009,"finding":"hnRNP-L binds the right terminal stem-loop domain of HDV genomic RNA in vitro and co-immunoprecipitates with both polarities of HDV RNA within HeLa cells, indicating it is a host factor that associates with the HDV replication complex.","method":"UV cross-linking/mass spectrometry, RNA affinity chromatography, co-immunoprecipitation in HeLa cells","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal binding assays (affinity chromatography + co-IP) in a single lab; no functional perturbation reported","pmids":["19464723"],"is_preprint":false},{"year":2017,"finding":"hnRNP-L knockdown in bladder cancer cells results in G1-phase cell cycle arrest, enhanced apoptosis, decreased Bcl-2, increased caspase-3/-6/-9, and inhibition of MAPK signaling, establishing hnRNP-L as a pro-survival factor that sustains MAPK signaling and suppresses intrinsic apoptosis.","method":"siRNA knockdown, cell cycle analysis, apoptosis assay, xenograft tumor model, western blotting","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with defined cellular and in vivo phenotypes plus pathway protein readouts; single lab","pmids":["28088793"],"is_preprint":false},{"year":2017,"finding":"HnRNP-L promotes prostate cancer cell proliferation by binding p53 mRNA (confirmed by RIP) affecting p21/cyclin levels, and promotes anti-apoptosis by directly binding BCL-2.","method":"RNA immunoprecipitation (RIP), co-immunoprecipitation, siRNA/overexpression, xenograft model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP confirms direct mRNA binding, corroborated by functional assays; single lab","pmids":["28038443"],"is_preprint":false},{"year":2019,"finding":"FBXO16, an F-box E3 ubiquitin ligase, assembles an SCF complex that directly ubiquitinates hnRNPL for proteasomal degradation by binding to the RRM3 domain of hnRNPL via FBXO16's C-terminal region.","method":"Co-immunoprecipitation, ubiquitination assay, domain-mapping, siRNA/KO, xenograft model","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro ubiquitination assay, domain mapping, epistasis rescue, and in vivo validation; multiple orthogonal methods in single study","pmids":["34333526"],"is_preprint":false},{"year":2021,"finding":"HNRNPL promotes the stability of hnRNPL protein by protecting it from polyubiquitination and proteasomal degradation when the lncRNA CASC8 binds to it; CASC8-hnRNPL interaction inhibits hnRNPL polyubiquitination.","method":"Co-immunoprecipitation, ubiquitination assay, RNA pulldown, siRNA knockdown, xenograft model","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ubiquitination assay, two orthogonal methods; single lab","pmids":["35982900"],"is_preprint":false},{"year":2021,"finding":"HNRNPL binds to the lncRNA SNHG1 and this interaction impairs HNRNPL's ability to promote E-cadherin (CDH1) mRNA translation, thereby activating EMT in prostate cancer cells.","method":"RNA pulldown, RIP, RNA-seq, immunoblotting, rescue experiments","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP + RNA pulldown demonstrate interaction; translational effect inferred from rescue; single lab","pmids":["33542227"],"is_preprint":false},{"year":2021,"finding":"HNRNPL binds the lncRNA SNHG6 and normally stabilizes SETD7 mRNA; when SNHG6 acts as a decoy to sequester HNRNPL, SETD7 mRNA stability is reduced, promoting HCC progression.","method":"Quantitative proteomics, RNA pulldown, RIP, siRNA knockdown, rescue experiments","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics-identified interaction validated by RIP and pulldown, with mRNA stability readout; single lab","pmids":["34252487"],"is_preprint":false},{"year":2020,"finding":"Cytoplasmic hnRNPL stabilizes MTNR1A mRNA through CA-repeat elements in its coding region, protecting the transcript from degradation by exosome component 10 (EXOSC10); hnRNPL knockdown or overexpression correspondingly decreases or increases MTNR1A RNA and downstream cAMP-CREB signaling.","method":"RNA interference screen, hnRNPL knockdown/overexpression, mRNA stability assay, RIP, western blotting","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi screen, RIP confirming CA-repeat element binding, mRNA stability assay, identification of EXOSC10 as the degradation machinery; multiple orthogonal methods","pmids":["32730662"],"is_preprint":false},{"year":2020,"finding":"Protein kinase C theta (PKCθ) signaling modulates hnRNPL activity in induced regulatory T cells; loss of PKCθ function alters hnRNPL-dependent post-transcriptional regulation, which in turn controls PCMT1 expression and FOXP3 stability.","method":"Cell-penetrating peptide mimic delivery, RNA processing analysis, knockdown/overexpression, flow cytometry","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanistic chain inferred from pharmacological perturbation; direct phosphorylation of hnRNPL by PKCθ not biochemically demonstrated in this abstract","pmids":["32592691"],"is_preprint":false},{"year":2019,"finding":"hnRNPL binds chromatin at integrin and extracellular matrix genes in epidermal stem cells, recruits RNA polymerase II to these loci, and stabilizes Pol II transcription through these genes; HNRNPL loss causes premature differentiation and detachment of the basal epidermal layer due to diminished integrin/ECM expression.","method":"ChIP, ChIP-seq, siRNA knockdown in primary human keratinocytes, in vivo mouse epidermis KO, RNA-seq","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP confirms chromatin occupancy, KO with defined in vivo phenotype, and RNA-seq for genome-wide expression; multiple orthogonal methods in single study","pmids":["34543262"],"is_preprint":false},{"year":2012,"finding":"hnRNPL knockdown in spermatogenic cells leads to inhibited proliferation and increased apoptosis, whereas knockdown in Sertoli cells decreases apoptosis; hnRNPL regulates CEACAM1 in GC-1 spermatogenic cells and iNOS in TM4 Sertoli cells, establishing hnRNPL as a key regulator of spermatogenesis.","method":"2D-gel proteomics, MALDI-TOF MS, siRNA knockdown in vitro and in vivo, immunohistochemistry, western blotting","journal":"Journal of proteomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics discovery combined with functional siRNA KD in two cell types with defined molecular targets; single lab","pmids":["22245417"],"is_preprint":false},{"year":2019,"finding":"hnRNPL directly targets p53 mRNA (confirmed by RIP) in Wilms tumor cells; knockdown of hnRNPL inhibits expression of both p53 and Bcl-2, reduces proliferation, and promotes apoptosis in vitro and suppresses xenograft growth in vivo.","method":"RIP, siRNA knockdown, MTT assay, flow cytometry, RT-qPCR, western blot, xenograft model","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP confirms direct mRNA binding; functional assays corroborate; single lab","pmids":["31213844"],"is_preprint":false},{"year":2019,"finding":"hnRNPL inhibits osteogenic differentiation of periodontal ligament stem cells by down-regulating the H3K36me3 methyltransferase SETD2; the AKT pathway governs hnRNPL levels in response to Sr ions.","method":"Knockdown/overexpression, western blotting, osteogenic differentiation assay, AKT pathway inhibitor","journal":"Journal of cellular and molecular medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, limited mechanistic depth; SETD2 regulation by hnRNPL shown by expression change but direct interaction not biochemically confirmed in the abstract","pmids":["30746871"],"is_preprint":false},{"year":2019,"finding":"HNRNPL binds the 3′UTR of BUB1 mRNA at the polymorphic marker D2S1888 and blocks miR-155 targeting of BUB1, thereby restoring BUB1 protein expression and stabilizing karyotypes in chronic lymphocytic leukemia-derived transformed cells.","method":"RNA binding assay, expression analysis of BUB1 vs miR-155, knockdown/rescue experiments","journal":"Cancers","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanism inferred from expression correlation and partial binding assay; direct competition not demonstrated by reconstitution","pmids":["31018621"],"is_preprint":false},{"year":2022,"finding":"lncFAM71E1-2:2 (lncFAM) recruits HNRNPL to the MYBPC2 promoter, increasing MYBPC2 mRNA transcription and production of the myogenic protein MYBPC2 to promote human myoblast differentiation into myotubes.","method":"ChIRP-MS, ChIRP, siRNA knockdown/overexpression, myotube differentiation assay, qPCR","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIRP-MS identifies interaction, confirmed at promoter level; functional differentiation assay; single lab","pmids":["36533518"],"is_preprint":false},{"year":2024,"finding":"hnRNPL is essential for B cell activation, germinal center formation, and antibody responses; it regulates alternative splicing of histone modifiers KDM6A and SIRT1 (conserved across ≥8 cell types), and its loss causes global changes in H3K27me3 and H3K9ac, dysfunctional mitochondria, and ROS overproduction in mouse B cells.","method":"Conditional KO mice, RNA-seq (comparative across 8+ cell types), H3K27me3/H3K9ac ChIP, flow cytometry, proliferation/apoptosis assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined cellular phenotypes, comparative RNA-seq across multiple cell types, ChIP for histone marks; multiple orthogonal methods","pmids":["38744970"],"is_preprint":false},{"year":2025,"finding":"hnRNPL forms phase-separated condensates on chromatin that activate PIK3CB transcription and glycolysis in ovarian cancer cells; a non-coding RNA transcribed from the PIK3CB promoter interacts with hnRNPL and promotes its condensation.","method":"ChIP, phase-separation assays, RNA immunoprecipitation, CDX and PDO models, hnRNPL KD/OE, glycolysis measurement","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, phase-separation assays, RIP, and functional xenograft/organoid models; multiple orthogonal methods in one study","pmids":["40413189"],"is_preprint":false},{"year":2023,"finding":"HNRNPL stabilizes circMGA RNA, and the circMGA/HNRNPL complex stabilizes CCL5 mRNA, promoting CCL5 secretion and CD8+ T cell chemoattraction in bladder cancer; in turn, HNRNPL increases circMGA stability, forming a positive feedback loop.","method":"RIP, RNA pulldown, siRNA knockdown, luciferase assay, mouse xenograft with immune reconstitution","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP and RNA pulldown confirm interaction; mRNA stability and in vivo immune phenotype measured; single lab","pmids":["36869127"],"is_preprint":false},{"year":2023,"finding":"HNRNPL and PTBP1 protect CFTR mRNA from nonsense-mediated decay (NMD); depletion of HNRNPL specifically reduces CFTR mRNA abundance (increases mRNA decay) in cells bearing G542X or W1282X nonsense alleles, while HNRNPL overexpression increases CFTR mRNA levels most prominently in these nonsense-allele lines.","method":"siRNA depletion, exogenous overexpression, quantitative PCR for mRNA abundance and decay rate in 16HBE14o- cells","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional KD/OE with quantitative mRNA decay readout; two allele contexts tested; single lab","pmids":["38045134"],"is_preprint":false},{"year":2025,"finding":"hnRNPL promotes exon 13 skipping in SLK pre-mRNA by recognizing introns 12 and 13, generating the oncogenic SLK-S isoform that activates ERK signaling and enhances HCC cell invasion and metastasis.","method":"RNA pulldown, RIP, alternative splicing assays, siRNA knockdown/overexpression, invasion/metastasis assays, in vivo mouse model","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP and RNA pulldown confirm intronic binding; functional isoform-specific effects demonstrated; single lab","pmids":["41046074"],"is_preprint":false},{"year":2025,"finding":"hnRNPL forms a complex with CstF64 (a polyadenylation factor) associated with enhancer RNAs (eRNAs) at the IgH 3′ regulatory region; this hnRNPL/CstF64 complex promotes RNA polymerase II elongation and eRNA transcription at the 3′RR, and also promotes NHEJ-mediated DNA repair by facilitating 53BP1 and Ku80 recruitment, thereby regulating class switch recombination (CSR) and locus suicide recombination (LSR).","method":"Co-immunoprecipitation, ChIP, eRNA transcription assay, CSR/LSR reporter assays, NHEJ assay, 53BP1/Ku80 recruitment assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP, and functional CSR/NHEJ assays; multiple readouts; single lab","pmids":["40902003"],"is_preprint":false},{"year":2025,"finding":"SMG5-mediated NMD degrades PTC-containing Hnrnpl variant transcripts in oligodendrocyte lineage cells; loss of SMG5 increases these aberrant Hnrnpl variants and impairs oligodendrocyte differentiation; HNRNPL promotes alternative splicing of myelin-associated genes Mag and Nfasc to support oligodendrocyte differentiation.","method":"Conditional Smg5 KO in oligodendrocyte lineage, RNA-seq, myelin gene expression analysis, splicing assay, electron microscopy of myelin sheaths, motor function testing","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined in vivo phenotypes (myelin thickness, motor function), RNA-seq, specific splicing targets identified; multiple orthogonal methods","pmids":["40930975"],"is_preprint":false},{"year":2023,"finding":"KIT D816V mutation (but not wild-type KIT) specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells, without requiring the ligand SCF; wild-type KIT and HNRNPL have different subcellular distributions (nuclear for HNRNPL, cytosol/membrane for wild-type KIT), whereas KIT D816V is predominantly cytosolic.","method":"Immunoprecipitation, western blot, confocal microscopy, transfection of WT vs D816V KIT with HNRNPL","journal":"Xi bao yu fen zi mian yi xue za zhi","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method (IP/WB); functional consequences of HNRNPL phosphorylation not explored","pmids":["36872432"],"is_preprint":false},{"year":2025,"finding":"SENP3 interacts with HNRNPL and facilitates its deSUMOylation and proteasomal degradation in hepatocytes during acute liver injury; this reduction in HNRNPL decreases Neat1 lncRNA levels, impairing caspase-1 activation and pyroptosis.","method":"Co-immunoprecipitation, SUMOylation assay, SENP3 KO mice (hepatocyte-specific), Neat1/caspase-1 assay, western blotting","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, SUMOylation assay, and conditional KO with defined phenotype; epistasis through HNRNPL-Neat1-caspase-1 axis; single lab","pmids":["40792025"],"is_preprint":false},{"year":2024,"finding":"HNRNPL promotes S100A9 mRNA stability through direct RNA binding (confirmed by RIP and RNA pulldown), thereby sustaining ferroptosis in hepatocellular carcinoma cells by maintaining iron and ROS levels.","method":"RIP, RNA pulldown, actinomycin D mRNA stability assay, sh-HNRNPL and oe-S100A9 rescue, in vivo xenograft","journal":"Translational oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding confirmed by RIP and pulldown, mRNA stability measured, epistasis by rescue; single lab","pmids":["38368714"],"is_preprint":false},{"year":2018,"finding":"lncITPF binds hnRNP-L (confirmed by RNA pulldown, LC-MS, and RIP) and, through hnRNP-L, regulates H3 and H4 histone acetylation at the ITGBL1 promoter to promote pulmonary fibrosis.","method":"RNA pulldown, LC-MS, RIP, ChIP-qPCR, CRISPR-Cas9, siRNA knockdown","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three binding assays plus ChIP for histone marks; single lab","pmids":["30528088"],"is_preprint":false},{"year":2024,"finding":"hnRNPL regulates alternative splicing of tropomyosin in cardiac muscle cells (confirmed in C2C12 myoblasts); hnRNPL protein increases in failing hearts from mice with transaortic constriction-induced HF and from HF patients, and knockdown of the Drosophila ortholog Smooth induces cardiomyopathy.","method":"Computational binding site prediction, RT-PCR splicing assay in C2C12 myoblasts, Drosophila smooth KD, western blot from human/mouse heart tissue","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — splicing assay validates prediction, cross-species functional KD; single lab","pmids":["39300280"],"is_preprint":false},{"year":2025,"finding":"CircROR1 recruits HNRNPL to the nucleus and influences its nuclear translocation; the circROR1/HNRNPL complex prevents intron retention in FOXO4 mRNA, promoting FOXO4ζ isoform over FOXO4α and enhancing melanoma metastasis.","method":"RNA pulldown-MS, RIP, nuclear/cytoplasmic fractionation, FISH, RNA-seq, overexpression/KD, xenograft model","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pulldown-MS and RIP confirm interaction, isoform switching confirmed by RNA-seq, localization by fractionation+FISH; single lab","pmids":["41530849"],"is_preprint":false},{"year":2024,"finding":"hnRNPL increases WSB1 mRNA stability by directly binding WSB1 mRNA (confirmed by RIP and RNA pulldown), thereby promoting lipid droplet accumulation and proliferation in clear cell renal cell carcinoma cells.","method":"RIP, RNA pulldown, actinomycin D mRNA stability assay, CCK-8, Oil Red O/BODIPY staining, siRNA knockdown","journal":"Cell biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — RIP and pulldown show binding; single lab, no in vivo validation reported in abstract","pmids":["38822203"],"is_preprint":false}],"current_model":"HNRNPL is a multifunctional RNA-binding protein that (1) regulates alternative splicing of diverse pre-mRNAs (including myelin-associated genes, tropomyosin, SLK, and FOXO4) by binding CA-rich intronic elements; (2) stabilizes specific mRNAs (MTNR1A, p53, CCL5, S100A9, WSB1) in the cytoplasm through CA-repeat binding elements, protecting them from NMD or exosome-mediated decay; (3) acts on chromatin as a transcriptional co-activator by recruiting RNA Pol II to target gene loci and forming phase-separated condensates that activate transcription (e.g., PIK3CB, integrin/ECM genes); (4) interacts with P-TEFb components (CDK9, CCNT2, HEXIM1, 7SK RNA) to promote Pol II elongation and release from pausing; (5) forms lncRNA-dependent complexes at gene promoters to regulate transcription (e.g., THRIL-hnRNPL at TNFα, lncFAM-hnRNPL at MYBPC2, seRNA-1-hnRNPL at Mb); (6) serves as a structural adaptor in the Sam68 nuclear body by bridging two RNase-sensitive substructures; (7) is regulated post-translationally by FBXO16-SCF-mediated ubiquitination/proteasomal degradation and by SENP3-mediated deSUMOylation, as well as by phosphorylation induced by KIT D816V; and (8) is essential for B cell activation, oligodendrocyte differentiation, epidermal stem cell maintenance, and spermatogenesis."},"narrative":{"mechanistic_narrative":"HNRNPL is a multifunctional CA-rich-element-binding protein that integrates RNA processing with chromatin-based transcriptional control across diverse cell lineages [PMID:31857580, PMID:34543262, PMID:38744970]. As a splicing regulator, it recognizes intronic CA-rich elements to direct alternative splicing of specific pre-mRNAs—promoting exon 13 skipping in SLK to generate an oncogenic ERK-activating isoform [PMID:41046074], controlling tropomyosin splicing in cardiac muscle [PMID:39300280], preventing intron retention in FOXO4 [PMID:41530849], and supporting myelin gene (Mag, Nfasc) and histone-modifier (KDM6A, SIRT1) splicing programs that underlie oligodendrocyte differentiation and B cell activation [PMID:38744970, PMID:40930975]. In the cytoplasm it binds CA-repeat elements within target transcripts (MTNR1A, S100A9, WSB1, CCL5, CFTR) to stabilize them against exosome- and NMD-mediated decay, thereby tuning downstream signaling, ferroptosis, lipid metabolism, and immune chemoattraction [PMID:32730662, PMID:38368714, PMID:36869127, PMID:38045134]. On chromatin, HNRNPL acts as a transcriptional co-activator: it binds gene loci, recruits and stabilizes RNA polymerase II elongation, and forms phase-separated condensates that activate transcription of integrin/ECM genes in epidermal stem cells and PIK3CB in ovarian cancer [PMID:34543262, PMID:40413189]. This activity is frequently templated by non-coding RNAs—lncRNAs, enhancer RNAs, and promoter-derived transcripts (THRIL, seRNA-1, lncFAM, CASC8, SNHG1/6, circMGA)—that recruit or sequester HNRNPL at target promoters and modulate its stability and condensation [PMID:24371310, PMID:31857580, PMID:36533518, PMID:35982900, PMID:40413189, PMID:36869127]. It also delivers inactive P-TEFb (CDK9/CCNT2/HEXIM1/7SK) to promote Pol II elongation [PMID:24434558] and serves as a structural adaptor bridging RNase-sensitive substructures of the Sam68 nuclear body via its RRMs [PMID:27377249]. HNRNPL abundance is governed post-translationally by FBXO16-SCF-mediated ubiquitination and proteasomal degradation through its RRM3 domain [PMID:34333526] and by SENP3-mediated deSUMOylation [PMID:40792025]. Through these activities it is essential for B cell germinal-center responses, oligodendrocyte differentiation, epidermal stem cell maintenance, and spermatogenesis [PMID:38744970, PMID:40930975, PMID:34543262, PMID:22245417].","teleology":[{"year":2002,"claim":"First evidence that hnRNP-L participates directly in transcriptional regulation rather than RNA processing alone, by complexing with APE1 at a promoter repressor element.","evidence":"EMSA, UV cross-linking, and co-IP on the nCaRE-B2 element of the APE1 promoter","pmids":["11809897"],"confidence":"Medium","gaps":["Protein-protein interaction shown but functional transcriptional output not measured genome-wide","Single lab, single promoter context"]},{"year":2009,"claim":"Established hnRNP-L as a host RNA-binding factor that can be co-opted by viral replication complexes, binding HDV genomic RNA.","evidence":"UV cross-linking/MS, RNA affinity chromatography, and co-IP in HeLa cells","pmids":["19464723"],"confidence":"Medium","gaps":["No functional perturbation of HDV replication shown","RNA element binding characterized only in vitro"]},{"year":2012,"claim":"Showed hnRNPL restrains genome mobility, acting as a negative regulator of LINE-1 retrotransposition through IRES RNA binding.","evidence":"RNA affinity chromatography, siRNA knockdown, and L1 retrotransposition reporter assay","pmids":["23161687"],"confidence":"High","gaps":["Mechanism by which binding suppresses ORF2 translation/retrotransposition not resolved","Endogenous L1 targets not mapped"]},{"year":2012,"claim":"Identified hnRNPL as a regulator of spermatogenesis with opposing roles in germ versus Sertoli cells.","evidence":"2D-gel proteomics, MALDI-TOF, and siRNA knockdown in GC-1 and TM4 cells with target validation (CEACAM1, iNOS)","pmids":["22245417"],"confidence":"Medium","gaps":["Direct RNA targets versus indirect effects not distinguished","Cell-type-specific opposing phenotype mechanism unexplained"]},{"year":2014,"claim":"Connected hnRNPL to Pol II elongation control by showing it delivers inactive P-TEFb to target loci, linking it to the 7SK snRNP.","evidence":"Genome-scale shRNA screen, co-IP with CDK9/CCNT2/HEXIM1/7SK, flavopiridol-sensitivity, and in vivo KD","pmids":["24434558"],"confidence":"High","gaps":["How hnRNPL selects elongation-dependent target genes unclear","Direct versus 7SK-bridged interactions not fully dissected"]},{"year":2016,"claim":"Defined a structural role for HNRNPL as an architectural adaptor bridging two RNase-sensitive substructures of the Sam68 nuclear body.","evidence":"Fluorescent cDNA screen of 32,651 clones, RNase treatment, systematic siRNA KD, and confocal imaging","pmids":["27377249"],"confidence":"High","gaps":["Identity of the architectural RNAs bound by each RRM set not determined","Function of the SNB itself remains unclear"]},{"year":2013,"claim":"First lncRNA-templated transcriptional role: THRIL recruits hnRNPL to the TNFα promoter, establishing the recurring paradigm of ncRNA-guided HNRNPL chromatin recruitment.","evidence":"Reciprocal RIP, RNA pulldown, ChIP, and lentiviral KD with transcriptome analysis in macrophages","pmids":["24371310"],"confidence":"High","gaps":["Whether HNRNPL activates or represses depends on context not generalized here","Mechanism of Pol II engagement at the promoter not resolved"]},{"year":2017,"claim":"Defined a pro-survival, oncogenic function in tumor cells through stabilization/binding of p53 and BCL-2 transcripts and sustained MAPK signaling.","evidence":"RIP, co-IP, siRNA/overexpression, and xenograft models in bladder and prostate cancer cells","pmids":["28088793","28038443"],"confidence":"Medium","gaps":["Direct versus indirect effects on p21/cyclin levels not separated","RNA binding elements within targets not mapped"]},{"year":2019,"claim":"Generalized HNRNPL as an enhancer-RNA-associated co-activator: seRNA-1 recruits it to drive Pol II and H3K36me3 deposition during myogenesis, with transcriptome-wide eRNA association.","evidence":"RIP, ChIRP, ChIP for Pol II/H3K36me3, and in vivo loss-of-function during myogenic differentiation","pmids":["31857580"],"confidence":"High","gaps":["How eRNA binding mechanistically stabilizes Pol II not defined","Selectivity of HNRNPL for specific enhancers unexplained"]},{"year":2019,"claim":"Demonstrated HNRNPL chromatin co-activator function is required for tissue homeostasis: it binds integrin/ECM gene loci, recruits Pol II, and maintains epidermal stem cells.","evidence":"ChIP, ChIP-seq, siRNA KD in keratinocytes, and conditional KO mouse epidermis with RNA-seq","pmids":["34543262"],"confidence":"High","gaps":["Whether recruitment is RNA-dependent at these loci not tested","Distinction from splicing-based contributions to phenotype incomplete"]},{"year":2019,"claim":"Established post-translational control of HNRNPL abundance via FBXO16-SCF ubiquitination targeting its RRM3 domain.","evidence":"Co-IP, in vitro ubiquitination assay, domain mapping, KO/rescue, and xenograft model","pmids":["34333526"],"confidence":"High","gaps":["Signals triggering FBXO16-mediated degradation not identified","Functional consequences for splicing/transcription targets not surveyed"]},{"year":2020,"claim":"Defined the cytoplasmic mRNA-stabilizing mechanism: HNRNPL binds CA-repeat coding-region elements to protect MTNR1A from EXOSC10-mediated decay.","evidence":"RNAi screen, RIP, mRNA stability assay, and KD/OE with downstream cAMP-CREB readout","pmids":["32730662"],"confidence":"High","gaps":["How HNRNPL antagonizes the exosome mechanistically not resolved","Breadth of CA-repeat target transcriptome not mapped here"]},{"year":2021,"claim":"Showed lncRNAs can both stabilize HNRNPL protein (CASC8 blocking polyubiquitination) and act as decoys to sequester it from mRNA targets (SNHG1, SNHG6), tuning its functional output.","evidence":"RNA pulldown, RIP, ubiquitination/co-IP assays, and rescue experiments in cancer models","pmids":["35982900","33542227","34252487"],"confidence":"Medium","gaps":["Competition stoichiometry between decoy lncRNAs and mRNA targets not quantified","Single-lab studies per lncRNA"]},{"year":2024,"claim":"Demonstrated splicing-program control underlies HNRNPL essentiality in B cell activation, regulating histone modifiers (KDM6A, SIRT1) and shaping global histone marks and mitochondrial function.","evidence":"Conditional KO mice, comparative RNA-seq across 8+ cell types, and H3K27me3/H3K9ac ChIP","pmids":["38744970"],"confidence":"High","gaps":["Direct splicing targets versus downstream chromatin effects not fully separated","Mechanism linking splicing changes to ROS not resolved"]},{"year":2024,"claim":"Extended cytoplasmic mRNA stabilization to metabolic and immune outputs by stabilizing S100A9, WSB1, and CCL5 transcripts.","evidence":"RIP, RNA pulldown, actinomycin D decay assays, and rescue/xenograft models","pmids":["38368714","38822203","36869127"],"confidence":"Medium","gaps":["Whether all targets share the CA-repeat recognition mode not confirmed","circMGA positive-feedback mechanism mechanistically incomplete"]},{"year":2023,"claim":"Identified an NMD-protective function: HNRNPL (with PTBP1) shields CFTR mRNA bearing nonsense alleles from decay.","evidence":"siRNA depletion and overexpression with quantitative mRNA decay measurement in 16HBE14o- cells across G542X/W1282X contexts","pmids":["38045134"],"confidence":"Medium","gaps":["Binding site on CFTR mRNA not mapped","Mechanism of NMD antagonism not defined"]},{"year":2025,"claim":"Established that HNRNPL forms chromatin phase-separated condensates that activate transcription, templated by a promoter-derived non-coding RNA at PIK3CB.","evidence":"ChIP, phase-separation assays, RIP, and CDX/PDO models with glycolysis measurement","pmids":["40413189"],"confidence":"High","gaps":["Domains driving condensation not mapped","Generality of condensate-driven activation across loci not established"]},{"year":2025,"claim":"Connected HNRNPL splicing activity to in vivo myelination via NMD-controlled levels and Mag/Nfasc splicing in oligodendrocytes.","evidence":"Conditional Smg5 KO in oligodendrocyte lineage, RNA-seq, splicing assays, EM of myelin, and motor testing","pmids":["40930975"],"confidence":"High","gaps":["Direct splicing mechanism on Mag/Nfasc introns not biochemically detailed","HNRNPL auto-regulation through NMD not fully traced"]},{"year":2025,"claim":"Added a chromatin/DNA-repair role: an HNRNPL/CstF64-eRNA complex at the IgH 3'RR promotes Pol II elongation and NHEJ-mediated repair to govern class switch and locus suicide recombination.","evidence":"Co-IP, ChIP, eRNA transcription assays, CSR/LSR reporters, NHEJ assay, and 53BP1/Ku80 recruitment","pmids":["40902003"],"confidence":"Medium","gaps":["How HNRNPL facilitates 53BP1/Ku80 recruitment mechanistically unclear","Direct versus eRNA-mediated contributions not separated"]},{"year":2025,"claim":"Identified SENP3-mediated deSUMOylation as a second post-translational route controlling HNRNPL stability and a downstream Neat1-caspase-1 pyroptosis axis in liver injury.","evidence":"Co-IP, SUMOylation assay, and hepatocyte-specific SENP3 KO mice with Neat1/caspase-1 readout","pmids":["40792025"],"confidence":"Medium","gaps":["SUMO acceptor sites on HNRNPL not mapped","Link between SUMO status and Neat1 regulation not mechanistically resolved"]},{"year":null,"claim":"How HNRNPL's distinct activities—CA-rich splicing, cytoplasmic mRNA stabilization, ncRNA-guided chromatin co-activation, and condensate formation—are coordinated and selected within a given cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking RRM usage to functional partitioning","Domain determinants of phase separation versus RNA binding undefined","Rules governing which ncRNA recruits versus sequesters HNRNPL unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[2,4,5,13,25,30,33]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[25,27,33,32]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,15,22,1]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[15,22]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[11,12]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,15,22,28,33]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13,30]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[15,22,26]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[13,24,25,27,33]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,5,15,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21,23,26]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[15,16,20,27]}],"complexes":["Sam68 nuclear body","P-TEFb / 7SK snRNP-associated complex","FBXO16-SCF E3 ligase complex","hnRNPL/CstF64 eRNA complex"],"partners":["APE1","CDK9","CCNT2","HEXIM1","FBXO16","SENP3","CSTF64","PTBP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P14866","full_name":"Heterogeneous nuclear ribonucleoprotein L","aliases":[],"length_aa":589,"mass_kda":64.1,"function":"Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements (PubMed:11809897, PubMed:22570490, PubMed:24164894, PubMed:25623890, PubMed:26051023). Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts (PubMed:2687284). Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter (PubMed:11809897). As part of a ribonucleoprotein complex composed at least of ZNF827, HNRNPK and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation (PubMed:33174841). Regulates alternative splicing of a core group of genes involved in neuronal differentiation, likely by mediating H3K36me3-coupled transcription elongation and co-transcriptional RNA processing via interaction with CHD8","subcellular_location":"Nucleus, nucleoplasm; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P14866/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/HNRNPL","classification":"Common Essential","n_dependent_lines":1178,"n_total_lines":1208,"dependency_fraction":0.9751655629139073},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000104824","cell_line_id":"CID001037","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"nuclear_punctae","grade":2}],"interactors":[{"gene":"HNRNPA2B1","stoichiometry":10.0},{"gene":"HNRNPC","stoichiometry":10.0},{"gene":"HNRNPA1;HNRNPA1L2","stoichiometry":10.0},{"gene":"HNRNPAB","stoichiometry":10.0},{"gene":"SUB1","stoichiometry":10.0},{"gene":"DDX21","stoichiometry":4.0},{"gene":"HNRNPD","stoichiometry":4.0},{"gene":"KHDRBS1","stoichiometry":4.0},{"gene":"HNRNPA0","stoichiometry":4.0},{"gene":"SSRP1","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001037","total_profiled":1310},"omim":[{"mim_id":"618217","title":"EGFR LONG NONCODING DOWNSTREAM RNA; ELDR","url":"https://www.omim.org/entry/618217"},{"mim_id":"615627","title":"BRI3-BINDING PROTEIN; BRI3BP","url":"https://www.omim.org/entry/615627"},{"mim_id":"615622","title":"TNF- AND HNRNPL-RELATED IMMUNOREGULATORY LONG NONCODING RNA; THRIL","url":"https://www.omim.org/entry/615622"},{"mim_id":"611208","title":"HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE; HNRNPLL","url":"https://www.omim.org/entry/611208"},{"mim_id":"603083","title":"HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL","url":"https://www.omim.org/entry/603083"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HNRNPL"},"hgnc":{"alias_symbol":[],"prev_symbol":["HNRPL"]},"alphafold":{"accession":"P14866","domains":[{"cath_id":"3.30.70.330","chopping":"102-172","consensus_level":"high","plddt":90.1808,"start":102,"end":172},{"cath_id":"3.30.70.330","chopping":"193-283","consensus_level":"high","plddt":87.9873,"start":193,"end":283},{"cath_id":"3.30.70.330","chopping":"380-482","consensus_level":"medium","plddt":92.1132,"start":380,"end":482},{"cath_id":"3.30.70.330","chopping":"497-589","consensus_level":"medium","plddt":89.9913,"start":497,"end":589}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14866","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14866-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14866-F1-predicted_aligned_error_v6.png","plddt_mean":73.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HNRNPL","jax_strain_url":"https://www.jax.org/strain/search?query=HNRNPL"},"sequence":{"accession":"P14866","fasta_url":"https://rest.uniprot.org/uniprotkb/P14866.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14866/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14866"}},"corpus_meta":[{"pmid":"24371310","id":"PMC_24371310","title":"The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24371310","citation_count":510,"is_preprint":false},{"pmid":"34258149","id":"PMC_34258149","title":"HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein.","date":"2021","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34258149","citation_count":108,"is_preprint":false},{"pmid":"36747239","id":"PMC_36747239","title":"HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36747239","citation_count":82,"is_preprint":false},{"pmid":"11809897","id":"PMC_11809897","title":"Human AP-endonuclease 1 and hnRNP-L interact with a nCaRE-like repressor element in the AP-endonuclease 1 promoter.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11809897","citation_count":76,"is_preprint":false},{"pmid":"23161687","id":"PMC_23161687","title":"hnRNPL and nucleolin bind LINE-1 RNA and function as host factors to modulate retrotransposition.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23161687","citation_count":75,"is_preprint":false},{"pmid":"31857580","id":"PMC_31857580","title":"MyoD induced enhancer RNA interacts with hnRNPL to activate target gene transcription during myogenic differentiation.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31857580","citation_count":73,"is_preprint":false},{"pmid":"32669100","id":"PMC_32669100","title":"A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.","date":"2020","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32669100","citation_count":66,"is_preprint":false},{"pmid":"31492748","id":"PMC_31492748","title":"Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/31492748","citation_count":60,"is_preprint":false},{"pmid":"24434558","id":"PMC_24434558","title":"An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24434558","citation_count":55,"is_preprint":false},{"pmid":"35982900","id":"PMC_35982900","title":"The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35982900","citation_count":53,"is_preprint":false},{"pmid":"27377249","id":"PMC_27377249","title":"The Sam68 nuclear body is composed of two RNase-sensitive substructures joined by the adaptor HNRNPL.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27377249","citation_count":53,"is_preprint":false},{"pmid":"30528088","id":"PMC_30528088","title":"lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1.","date":"2018","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30528088","citation_count":49,"is_preprint":false},{"pmid":"35278674","id":"PMC_35278674","title":"hnRNPL-activated circANKRD42 back-splicing and circANKRD42-mediated crosstalk of mechanical stiffness and biochemical signal in lung fibrosis.","date":"2022","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35278674","citation_count":42,"is_preprint":false},{"pmid":"33542227","id":"PMC_33542227","title":"LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33542227","citation_count":40,"is_preprint":false},{"pmid":"22245417","id":"PMC_22245417","title":"HnRNPL as a key factor in spermatogenesis: Lesson from functional proteomic studies of azoospermia patients with sertoli cell only syndrome.","date":"2012","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/22245417","citation_count":40,"is_preprint":false},{"pmid":"19464723","id":"PMC_19464723","title":"The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2.","date":"2009","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/19464723","citation_count":40,"is_preprint":false},{"pmid":"32376323","id":"PMC_32376323","title":"Heterogeneous nuclear ribonucleoprotein (hnRNPL) in cancer.","date":"2020","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32376323","citation_count":36,"is_preprint":false},{"pmid":"28088793","id":"PMC_28088793","title":"HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28088793","citation_count":34,"is_preprint":false},{"pmid":"34333526","id":"PMC_34333526","title":"FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34333526","citation_count":30,"is_preprint":false},{"pmid":"28038443","id":"PMC_28038443","title":"HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28038443","citation_count":30,"is_preprint":false},{"pmid":"34252487","id":"PMC_34252487","title":"lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34252487","citation_count":28,"is_preprint":false},{"pmid":"29187863","id":"PMC_29187863","title":"Smooth, an hnRNP-L Homolog, Might Decrease Mitochondrial Metabolism by Post-Transcriptional Regulation of Isocitrate Dehydrogenase (Idh) and Other Metabolic Genes in the Sub-Acute Phase of Traumatic Brain Injury.","date":"2017","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29187863","citation_count":26,"is_preprint":false},{"pmid":"31930565","id":"PMC_31930565","title":"Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1.","date":"2020","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31930565","citation_count":25,"is_preprint":false},{"pmid":"36869127","id":"PMC_36869127","title":"Regulation of CD8+ T cells infiltration and immunotherapy by circMGA/HNRNPL complex in bladder cancer.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36869127","citation_count":24,"is_preprint":false},{"pmid":"27689400","id":"PMC_27689400","title":"Long noncoding RNA uc.345 promotes tumorigenesis of pancreatic cancer by upregulation of hnRNPL expression.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27689400","citation_count":22,"is_preprint":false},{"pmid":"32037441","id":"PMC_32037441","title":"Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32037441","citation_count":18,"is_preprint":false},{"pmid":"30746871","id":"PMC_30746871","title":"HnRNPL inhibits the osteogenic differentiation of PDLCs stimulated by SrCl2 through repressing Setd2.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30746871","citation_count":18,"is_preprint":false},{"pmid":"36925052","id":"PMC_36925052","title":"Circular RNA CircPDS5B impairs angiogenesis following ischemic stroke through its interaction with hnRNPL to inactivate VEGF-A.","date":"2023","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36925052","citation_count":17,"is_preprint":false},{"pmid":"38744970","id":"PMC_38744970","title":"Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/38744970","citation_count":16,"is_preprint":false},{"pmid":"40091520","id":"PMC_40091520","title":"ADAR1-HNRNPL-Mediated CircCANX Decline Promotes Autophagy in Chronic Obstructive Pulmonary Disease.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40091520","citation_count":15,"is_preprint":false},{"pmid":"31213844","id":"PMC_31213844","title":"HnRNPL promotes Wilms tumor progression by regulating the p53 and Bcl2 pathways.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31213844","citation_count":15,"is_preprint":false},{"pmid":"36533518","id":"PMC_36533518","title":"Enhanced myogenesis through lncFAM-mediated recruitment of HNRNPL to the MYBPC2 promoter.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36533518","citation_count":15,"is_preprint":false},{"pmid":"20237420","id":"PMC_20237420","title":"NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20237420","citation_count":14,"is_preprint":false},{"pmid":"32592691","id":"PMC_32592691","title":"Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32592691","citation_count":13,"is_preprint":false},{"pmid":"34543262","id":"PMC_34543262","title":"Regulation of integrin and extracellular matrix genes by HNRNPL is necessary for epidermal renewal.","date":"2021","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/34543262","citation_count":13,"is_preprint":false},{"pmid":"35258167","id":"PMC_35258167","title":"LINC01588 regulates WWP2-mediated cardiomyocyte injury by interacting with HNRNPL.","date":"2022","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35258167","citation_count":11,"is_preprint":false},{"pmid":"31018621","id":"PMC_31018621","title":"HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31018621","citation_count":11,"is_preprint":false},{"pmid":"33418347","id":"PMC_33418347","title":"HNRNPL affects the proliferation and apoptosis of colorectal cancer cells by regulating PD-L1.","date":"2020","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/33418347","citation_count":10,"is_preprint":false},{"pmid":"32730662","id":"PMC_32730662","title":"The MTNR1A mRNA is stabilized by the cytoplasmic hnRNPL in renal tubular cells.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32730662","citation_count":8,"is_preprint":false},{"pmid":"38368714","id":"PMC_38368714","title":"HNRNPL facilitates ferroptosis in hepatocellular carcinoma cells by promoting S100A9 expression.","date":"2024","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38368714","citation_count":7,"is_preprint":false},{"pmid":"29908545","id":"PMC_29908545","title":"Expression of TNF- and HNRNPL-related Immunoregulatory Long Non-coding RNA (THRIL) in Acute Myeloid Leukemia: Is There Any Correlation?","date":"2018","source":"Iranian journal of allergy, asthma, and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29908545","citation_count":7,"is_preprint":false},{"pmid":"12576095","id":"PMC_12576095","title":"PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR.","date":"2003","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12576095","citation_count":7,"is_preprint":false},{"pmid":"35549989","id":"PMC_35549989","title":"Long non-coding RNA lincRNA-erythroid prosurvival (EPS) alleviates cerebral ischemia/reperfusion injury by maintaining high-temperature requirement protein A1 (Htra1) stability through recruiting heterogeneous nuclear ribonucleoprotein L (HNRNPL).","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35549989","citation_count":5,"is_preprint":false},{"pmid":"40413189","id":"PMC_40413189","title":"hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40413189","citation_count":4,"is_preprint":false},{"pmid":"38045134","id":"PMC_38045134","title":"RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38045134","citation_count":4,"is_preprint":false},{"pmid":"37148985","id":"PMC_37148985","title":"hnRNPL expression dynamics in the embryo and placenta.","date":"2023","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/37148985","citation_count":3,"is_preprint":false},{"pmid":"41046074","id":"PMC_41046074","title":"Exon 13 skipping mediated by HNRNPL facilitates truncated SLK-induced metastasis in hepatocellular carcinoma.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41046074","citation_count":3,"is_preprint":false},{"pmid":"40930975","id":"PMC_40930975","title":"Smg5 Enhances Oligodendrocyte Differentiation via Nonsense-Mediated mRNA Decay of Hnrnpl Variant Transcripts.","date":"2025","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40930975","citation_count":2,"is_preprint":false},{"pmid":"40902003","id":"PMC_40902003","title":"hnRNPL-CstF64 complex: coordinating CSR and LSR in IgH locus recombination dynamics through eRNA and NHEJ regulation.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/40902003","citation_count":1,"is_preprint":false},{"pmid":"36872432","id":"PMC_36872432","title":"[D816V mutation of KIT specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells].","date":"2023","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36872432","citation_count":1,"is_preprint":false},{"pmid":"39300280","id":"PMC_39300280","title":"The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failure.","date":"2024","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/39300280","citation_count":1,"is_preprint":false},{"pmid":"40702809","id":"PMC_40702809","title":"CircCDYL Association With hnRNPL Modulates CDYL Isoform Switching in Breast Cancer Cells.","date":"2025","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/40702809","citation_count":0,"is_preprint":false},{"pmid":"38822203","id":"PMC_38822203","title":"HNRNPL Increases WSB1 mRNA Stability to Promote Proliferation and Lipid Droplets in Clear Cell Renal Cell Carcinoma.","date":"2024","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/38822203","citation_count":0,"is_preprint":false},{"pmid":"40792025","id":"PMC_40792025","title":"SENP3 protects hepatocyte from pyroptosis during acute liver injury through deSUMOylation of HNRNPL.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/40792025","citation_count":0,"is_preprint":false},{"pmid":"42080810","id":"PMC_42080810","title":"LINC01012 Drives Hepatitis B-Related Hepatocellular Carcinoma Progression Through HNRNPL-Mediated Stabilization of Serine/Threonine-Protein Kinase-S.","date":"2026","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/42080810","citation_count":0,"is_preprint":false},{"pmid":"41530849","id":"PMC_41530849","title":"CircROR1 binds HNRNPL to regulate FOXO4 pre-mRNA splicing, promoting cutaneous melanoma metastasis and serving as a therapeutic target via RNAi-loaded PEG-LNPs.","date":"2026","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/41530849","citation_count":0,"is_preprint":false},{"pmid":"40944391","id":"PMC_40944391","title":"The impact of Hnrnpl deficiency on transcriptional patterns of developing muscle cells.","date":"2025","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/40944391","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.02.657432","title":"The Regulation of COX-2, ABCA1 and ABCG1 by the lncRNA PACERR links the inflammatory response and cholesterol homeostasis","date":"2025-06-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.02.657432","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.19.638943","title":"Resistance to Radiation Enhances Metastasis by Altering RNA Metabolism","date":"2025-02-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.19.638943","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.27.620453","title":"Proximity Interactome analyses unveil novel regulators of IRE1α canonical signaling","date":"2024-10-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.27.620453","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":32004,"output_tokens":8382,"usd":0.110871,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18058,"output_tokens":6272,"usd":0.123545,"stage2_stop_reason":"end_turn"},"total_usd":0.234416,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"hnRNPL binds to the lncRNA THRIL (linc1992) and the THRIL-hnRNPL complex regulates transcription of the TNFα gene by binding to its promoter in THP1 macrophages.\",\n      \"method\": \"RNA immunoprecipitation, RNA pulldown, ChIP, lentiviral knockdown with transcriptome analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal RIP, promoter ChIP, and KD with transcriptome readout, multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"24371310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"hnRNP-L and APE1 form a protein complex that binds the nCaRE-B2 repressor element in the APE1 promoter, and the APE1–hnRNP-L protein–protein interaction does not require the nCaRE-B2 DNA element, identifying a novel transcriptional regulatory role for hnRNP-L.\",\n      \"method\": \"Electrophoretic mobility shift assay, UV cross-linking, co-immunoprecipitation, pulldown assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and EMSA in a single lab with two orthogonal methods\",\n      \"pmids\": [\"11809897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"hnRNPL binds LINE-1 ORF2 IRES RNA (confirmed by RNA affinity chromatography) and functions as a negative regulator of L1 retrotransposition; hnRNPL knockdown dramatically increased L1 retrotransposition as well as L1 RNA and ORF1 protein levels.\",\n      \"method\": \"RNA affinity chromatography, siRNA knockdown, L1 retrotransposition reporter assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical binding assay combined with functional retrotransposition assay and protein/RNA abundance measurement; multiple orthogonal readouts in one study\",\n      \"pmids\": [\"23161687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"hnRNPL interacts with P-TEFb components CDK9, CCNT2, HEXIM1, and the 7SK RNA; hnRNPL knockdown reduces transcripts sensitive to the P-TEFb inhibitor flavopiridol and disrupts the association of 7SK RNA with Aire-containing complexes, indicating hnRNPL promotes RNA polymerase II elongation by facilitating delivery of inactive P-TEFb to Aire.\",\n      \"method\": \"Genome-scale shRNA screen, co-immunoprecipitation with P-TEFb components, flavopiridol-sensitivity assay, lentiviral KD mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — shRNA screen validated by co-IP, pharmacological inhibition, and in vivo KD; multiple orthogonal methods replicated on endogenous and transfected targets\",\n      \"pmids\": [\"24434558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HNRNPL acts as a structural adaptor in the Sam68 nuclear body (SNB), joining two distinct RNase-sensitive substructures (the DBC1 body substructure and the Sam68 substructure) through interactions of two sets of RNA recognition motifs (RRMs) with putative architectural RNAs in each substructure.\",\n      \"method\": \"Fluorescent cDNA screen of 32,651 clones for RNase-sensitive nuclear foci, RNase treatment, siRNA knockdown of each SNB protein, confocal microscopy\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — large-scale unbiased screen followed by RNase sensitivity assays and systematic individual KD with imaging; multiple orthogonal methods in one study\",\n      \"pmids\": [\"27377249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The seRNA-1 enhancer RNA interacts with hnRNPL via a CAAA tract; disrupting seRNA-1-hnRNPL interaction reduces RNA Pol II and H3K36me3 deposition at the myoglobin (Mb) locus and attenuates its transcription during myogenic differentiation. Transcriptome-wide analysis shows hnRNPL association with eRNAs is a general phenomenon.\",\n      \"method\": \"RNA immunoprecipitation, ChIRP, ChIP for Pol II and H3K36me3, in vitro and in vivo loss-of-function\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal RIP/ChIRP, ChIP readout, in vivo validation, and transcriptome-wide HNRNPL binding data; multiple orthogonal methods\",\n      \"pmids\": [\"31857580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"hnRNP-L binds the right terminal stem-loop domain of HDV genomic RNA in vitro and co-immunoprecipitates with both polarities of HDV RNA within HeLa cells, indicating it is a host factor that associates with the HDV replication complex.\",\n      \"method\": \"UV cross-linking/mass spectrometry, RNA affinity chromatography, co-immunoprecipitation in HeLa cells\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal binding assays (affinity chromatography + co-IP) in a single lab; no functional perturbation reported\",\n      \"pmids\": [\"19464723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"hnRNP-L knockdown in bladder cancer cells results in G1-phase cell cycle arrest, enhanced apoptosis, decreased Bcl-2, increased caspase-3/-6/-9, and inhibition of MAPK signaling, establishing hnRNP-L as a pro-survival factor that sustains MAPK signaling and suppresses intrinsic apoptosis.\",\n      \"method\": \"siRNA knockdown, cell cycle analysis, apoptosis assay, xenograft tumor model, western blotting\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with defined cellular and in vivo phenotypes plus pathway protein readouts; single lab\",\n      \"pmids\": [\"28088793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HnRNP-L promotes prostate cancer cell proliferation by binding p53 mRNA (confirmed by RIP) affecting p21/cyclin levels, and promotes anti-apoptosis by directly binding BCL-2.\",\n      \"method\": \"RNA immunoprecipitation (RIP), co-immunoprecipitation, siRNA/overexpression, xenograft model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP confirms direct mRNA binding, corroborated by functional assays; single lab\",\n      \"pmids\": [\"28038443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FBXO16, an F-box E3 ubiquitin ligase, assembles an SCF complex that directly ubiquitinates hnRNPL for proteasomal degradation by binding to the RRM3 domain of hnRNPL via FBXO16's C-terminal region.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, domain-mapping, siRNA/KO, xenograft model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro ubiquitination assay, domain mapping, epistasis rescue, and in vivo validation; multiple orthogonal methods in single study\",\n      \"pmids\": [\"34333526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HNRNPL promotes the stability of hnRNPL protein by protecting it from polyubiquitination and proteasomal degradation when the lncRNA CASC8 binds to it; CASC8-hnRNPL interaction inhibits hnRNPL polyubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, RNA pulldown, siRNA knockdown, xenograft model\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ubiquitination assay, two orthogonal methods; single lab\",\n      \"pmids\": [\"35982900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HNRNPL binds to the lncRNA SNHG1 and this interaction impairs HNRNPL's ability to promote E-cadherin (CDH1) mRNA translation, thereby activating EMT in prostate cancer cells.\",\n      \"method\": \"RNA pulldown, RIP, RNA-seq, immunoblotting, rescue experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP + RNA pulldown demonstrate interaction; translational effect inferred from rescue; single lab\",\n      \"pmids\": [\"33542227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HNRNPL binds the lncRNA SNHG6 and normally stabilizes SETD7 mRNA; when SNHG6 acts as a decoy to sequester HNRNPL, SETD7 mRNA stability is reduced, promoting HCC progression.\",\n      \"method\": \"Quantitative proteomics, RNA pulldown, RIP, siRNA knockdown, rescue experiments\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics-identified interaction validated by RIP and pulldown, with mRNA stability readout; single lab\",\n      \"pmids\": [\"34252487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cytoplasmic hnRNPL stabilizes MTNR1A mRNA through CA-repeat elements in its coding region, protecting the transcript from degradation by exosome component 10 (EXOSC10); hnRNPL knockdown or overexpression correspondingly decreases or increases MTNR1A RNA and downstream cAMP-CREB signaling.\",\n      \"method\": \"RNA interference screen, hnRNPL knockdown/overexpression, mRNA stability assay, RIP, western blotting\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi screen, RIP confirming CA-repeat element binding, mRNA stability assay, identification of EXOSC10 as the degradation machinery; multiple orthogonal methods\",\n      \"pmids\": [\"32730662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Protein kinase C theta (PKCθ) signaling modulates hnRNPL activity in induced regulatory T cells; loss of PKCθ function alters hnRNPL-dependent post-transcriptional regulation, which in turn controls PCMT1 expression and FOXP3 stability.\",\n      \"method\": \"Cell-penetrating peptide mimic delivery, RNA processing analysis, knockdown/overexpression, flow cytometry\",\n      \"journal\": \"Molecular therapy : the journal of the American Society of Gene Therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanistic chain inferred from pharmacological perturbation; direct phosphorylation of hnRNPL by PKCθ not biochemically demonstrated in this abstract\",\n      \"pmids\": [\"32592691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"hnRNPL binds chromatin at integrin and extracellular matrix genes in epidermal stem cells, recruits RNA polymerase II to these loci, and stabilizes Pol II transcription through these genes; HNRNPL loss causes premature differentiation and detachment of the basal epidermal layer due to diminished integrin/ECM expression.\",\n      \"method\": \"ChIP, ChIP-seq, siRNA knockdown in primary human keratinocytes, in vivo mouse epidermis KO, RNA-seq\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP confirms chromatin occupancy, KO with defined in vivo phenotype, and RNA-seq for genome-wide expression; multiple orthogonal methods in single study\",\n      \"pmids\": [\"34543262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"hnRNPL knockdown in spermatogenic cells leads to inhibited proliferation and increased apoptosis, whereas knockdown in Sertoli cells decreases apoptosis; hnRNPL regulates CEACAM1 in GC-1 spermatogenic cells and iNOS in TM4 Sertoli cells, establishing hnRNPL as a key regulator of spermatogenesis.\",\n      \"method\": \"2D-gel proteomics, MALDI-TOF MS, siRNA knockdown in vitro and in vivo, immunohistochemistry, western blotting\",\n      \"journal\": \"Journal of proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics discovery combined with functional siRNA KD in two cell types with defined molecular targets; single lab\",\n      \"pmids\": [\"22245417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"hnRNPL directly targets p53 mRNA (confirmed by RIP) in Wilms tumor cells; knockdown of hnRNPL inhibits expression of both p53 and Bcl-2, reduces proliferation, and promotes apoptosis in vitro and suppresses xenograft growth in vivo.\",\n      \"method\": \"RIP, siRNA knockdown, MTT assay, flow cytometry, RT-qPCR, western blot, xenograft model\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP confirms direct mRNA binding; functional assays corroborate; single lab\",\n      \"pmids\": [\"31213844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"hnRNPL inhibits osteogenic differentiation of periodontal ligament stem cells by down-regulating the H3K36me3 methyltransferase SETD2; the AKT pathway governs hnRNPL levels in response to Sr ions.\",\n      \"method\": \"Knockdown/overexpression, western blotting, osteogenic differentiation assay, AKT pathway inhibitor\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited mechanistic depth; SETD2 regulation by hnRNPL shown by expression change but direct interaction not biochemically confirmed in the abstract\",\n      \"pmids\": [\"30746871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HNRNPL binds the 3′UTR of BUB1 mRNA at the polymorphic marker D2S1888 and blocks miR-155 targeting of BUB1, thereby restoring BUB1 protein expression and stabilizing karyotypes in chronic lymphocytic leukemia-derived transformed cells.\",\n      \"method\": \"RNA binding assay, expression analysis of BUB1 vs miR-155, knockdown/rescue experiments\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanism inferred from expression correlation and partial binding assay; direct competition not demonstrated by reconstitution\",\n      \"pmids\": [\"31018621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"lncFAM71E1-2:2 (lncFAM) recruits HNRNPL to the MYBPC2 promoter, increasing MYBPC2 mRNA transcription and production of the myogenic protein MYBPC2 to promote human myoblast differentiation into myotubes.\",\n      \"method\": \"ChIRP-MS, ChIRP, siRNA knockdown/overexpression, myotube differentiation assay, qPCR\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIRP-MS identifies interaction, confirmed at promoter level; functional differentiation assay; single lab\",\n      \"pmids\": [\"36533518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"hnRNPL is essential for B cell activation, germinal center formation, and antibody responses; it regulates alternative splicing of histone modifiers KDM6A and SIRT1 (conserved across ≥8 cell types), and its loss causes global changes in H3K27me3 and H3K9ac, dysfunctional mitochondria, and ROS overproduction in mouse B cells.\",\n      \"method\": \"Conditional KO mice, RNA-seq (comparative across 8+ cell types), H3K27me3/H3K9ac ChIP, flow cytometry, proliferation/apoptosis assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined cellular phenotypes, comparative RNA-seq across multiple cell types, ChIP for histone marks; multiple orthogonal methods\",\n      \"pmids\": [\"38744970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"hnRNPL forms phase-separated condensates on chromatin that activate PIK3CB transcription and glycolysis in ovarian cancer cells; a non-coding RNA transcribed from the PIK3CB promoter interacts with hnRNPL and promotes its condensation.\",\n      \"method\": \"ChIP, phase-separation assays, RNA immunoprecipitation, CDX and PDO models, hnRNPL KD/OE, glycolysis measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, phase-separation assays, RIP, and functional xenograft/organoid models; multiple orthogonal methods in one study\",\n      \"pmids\": [\"40413189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HNRNPL stabilizes circMGA RNA, and the circMGA/HNRNPL complex stabilizes CCL5 mRNA, promoting CCL5 secretion and CD8+ T cell chemoattraction in bladder cancer; in turn, HNRNPL increases circMGA stability, forming a positive feedback loop.\",\n      \"method\": \"RIP, RNA pulldown, siRNA knockdown, luciferase assay, mouse xenograft with immune reconstitution\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP and RNA pulldown confirm interaction; mRNA stability and in vivo immune phenotype measured; single lab\",\n      \"pmids\": [\"36869127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HNRNPL and PTBP1 protect CFTR mRNA from nonsense-mediated decay (NMD); depletion of HNRNPL specifically reduces CFTR mRNA abundance (increases mRNA decay) in cells bearing G542X or W1282X nonsense alleles, while HNRNPL overexpression increases CFTR mRNA levels most prominently in these nonsense-allele lines.\",\n      \"method\": \"siRNA depletion, exogenous overexpression, quantitative PCR for mRNA abundance and decay rate in 16HBE14o- cells\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional KD/OE with quantitative mRNA decay readout; two allele contexts tested; single lab\",\n      \"pmids\": [\"38045134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"hnRNPL promotes exon 13 skipping in SLK pre-mRNA by recognizing introns 12 and 13, generating the oncogenic SLK-S isoform that activates ERK signaling and enhances HCC cell invasion and metastasis.\",\n      \"method\": \"RNA pulldown, RIP, alternative splicing assays, siRNA knockdown/overexpression, invasion/metastasis assays, in vivo mouse model\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP and RNA pulldown confirm intronic binding; functional isoform-specific effects demonstrated; single lab\",\n      \"pmids\": [\"41046074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"hnRNPL forms a complex with CstF64 (a polyadenylation factor) associated with enhancer RNAs (eRNAs) at the IgH 3′ regulatory region; this hnRNPL/CstF64 complex promotes RNA polymerase II elongation and eRNA transcription at the 3′RR, and also promotes NHEJ-mediated DNA repair by facilitating 53BP1 and Ku80 recruitment, thereby regulating class switch recombination (CSR) and locus suicide recombination (LSR).\",\n      \"method\": \"Co-immunoprecipitation, ChIP, eRNA transcription assay, CSR/LSR reporter assays, NHEJ assay, 53BP1/Ku80 recruitment assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP, and functional CSR/NHEJ assays; multiple readouts; single lab\",\n      \"pmids\": [\"40902003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SMG5-mediated NMD degrades PTC-containing Hnrnpl variant transcripts in oligodendrocyte lineage cells; loss of SMG5 increases these aberrant Hnrnpl variants and impairs oligodendrocyte differentiation; HNRNPL promotes alternative splicing of myelin-associated genes Mag and Nfasc to support oligodendrocyte differentiation.\",\n      \"method\": \"Conditional Smg5 KO in oligodendrocyte lineage, RNA-seq, myelin gene expression analysis, splicing assay, electron microscopy of myelin sheaths, motor function testing\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined in vivo phenotypes (myelin thickness, motor function), RNA-seq, specific splicing targets identified; multiple orthogonal methods\",\n      \"pmids\": [\"40930975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KIT D816V mutation (but not wild-type KIT) specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells, without requiring the ligand SCF; wild-type KIT and HNRNPL have different subcellular distributions (nuclear for HNRNPL, cytosol/membrane for wild-type KIT), whereas KIT D816V is predominantly cytosolic.\",\n      \"method\": \"Immunoprecipitation, western blot, confocal microscopy, transfection of WT vs D816V KIT with HNRNPL\",\n      \"journal\": \"Xi bao yu fen zi mian yi xue za zhi\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method (IP/WB); functional consequences of HNRNPL phosphorylation not explored\",\n      \"pmids\": [\"36872432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SENP3 interacts with HNRNPL and facilitates its deSUMOylation and proteasomal degradation in hepatocytes during acute liver injury; this reduction in HNRNPL decreases Neat1 lncRNA levels, impairing caspase-1 activation and pyroptosis.\",\n      \"method\": \"Co-immunoprecipitation, SUMOylation assay, SENP3 KO mice (hepatocyte-specific), Neat1/caspase-1 assay, western blotting\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, SUMOylation assay, and conditional KO with defined phenotype; epistasis through HNRNPL-Neat1-caspase-1 axis; single lab\",\n      \"pmids\": [\"40792025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HNRNPL promotes S100A9 mRNA stability through direct RNA binding (confirmed by RIP and RNA pulldown), thereby sustaining ferroptosis in hepatocellular carcinoma cells by maintaining iron and ROS levels.\",\n      \"method\": \"RIP, RNA pulldown, actinomycin D mRNA stability assay, sh-HNRNPL and oe-S100A9 rescue, in vivo xenograft\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding confirmed by RIP and pulldown, mRNA stability measured, epistasis by rescue; single lab\",\n      \"pmids\": [\"38368714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"lncITPF binds hnRNP-L (confirmed by RNA pulldown, LC-MS, and RIP) and, through hnRNP-L, regulates H3 and H4 histone acetylation at the ITGBL1 promoter to promote pulmonary fibrosis.\",\n      \"method\": \"RNA pulldown, LC-MS, RIP, ChIP-qPCR, CRISPR-Cas9, siRNA knockdown\",\n      \"journal\": \"Molecular therapy : the journal of the American Society of Gene Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three binding assays plus ChIP for histone marks; single lab\",\n      \"pmids\": [\"30528088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"hnRNPL regulates alternative splicing of tropomyosin in cardiac muscle cells (confirmed in C2C12 myoblasts); hnRNPL protein increases in failing hearts from mice with transaortic constriction-induced HF and from HF patients, and knockdown of the Drosophila ortholog Smooth induces cardiomyopathy.\",\n      \"method\": \"Computational binding site prediction, RT-PCR splicing assay in C2C12 myoblasts, Drosophila smooth KD, western blot from human/mouse heart tissue\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — splicing assay validates prediction, cross-species functional KD; single lab\",\n      \"pmids\": [\"39300280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CircROR1 recruits HNRNPL to the nucleus and influences its nuclear translocation; the circROR1/HNRNPL complex prevents intron retention in FOXO4 mRNA, promoting FOXO4ζ isoform over FOXO4α and enhancing melanoma metastasis.\",\n      \"method\": \"RNA pulldown-MS, RIP, nuclear/cytoplasmic fractionation, FISH, RNA-seq, overexpression/KD, xenograft model\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pulldown-MS and RIP confirm interaction, isoform switching confirmed by RNA-seq, localization by fractionation+FISH; single lab\",\n      \"pmids\": [\"41530849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"hnRNPL increases WSB1 mRNA stability by directly binding WSB1 mRNA (confirmed by RIP and RNA pulldown), thereby promoting lipid droplet accumulation and proliferation in clear cell renal cell carcinoma cells.\",\n      \"method\": \"RIP, RNA pulldown, actinomycin D mRNA stability assay, CCK-8, Oil Red O/BODIPY staining, siRNA knockdown\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — RIP and pulldown show binding; single lab, no in vivo validation reported in abstract\",\n      \"pmids\": [\"38822203\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HNRNPL is a multifunctional RNA-binding protein that (1) regulates alternative splicing of diverse pre-mRNAs (including myelin-associated genes, tropomyosin, SLK, and FOXO4) by binding CA-rich intronic elements; (2) stabilizes specific mRNAs (MTNR1A, p53, CCL5, S100A9, WSB1) in the cytoplasm through CA-repeat binding elements, protecting them from NMD or exosome-mediated decay; (3) acts on chromatin as a transcriptional co-activator by recruiting RNA Pol II to target gene loci and forming phase-separated condensates that activate transcription (e.g., PIK3CB, integrin/ECM genes); (4) interacts with P-TEFb components (CDK9, CCNT2, HEXIM1, 7SK RNA) to promote Pol II elongation and release from pausing; (5) forms lncRNA-dependent complexes at gene promoters to regulate transcription (e.g., THRIL-hnRNPL at TNFα, lncFAM-hnRNPL at MYBPC2, seRNA-1-hnRNPL at Mb); (6) serves as a structural adaptor in the Sam68 nuclear body by bridging two RNase-sensitive substructures; (7) is regulated post-translationally by FBXO16-SCF-mediated ubiquitination/proteasomal degradation and by SENP3-mediated deSUMOylation, as well as by phosphorylation induced by KIT D816V; and (8) is essential for B cell activation, oligodendrocyte differentiation, epidermal stem cell maintenance, and spermatogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HNRNPL is a multifunctional CA-rich-element-binding protein that integrates RNA processing with chromatin-based transcriptional control across diverse cell lineages [#5, #15, #21]. As a splicing regulator, it recognizes intronic CA-rich elements to direct alternative splicing of specific pre-mRNAs—promoting exon 13 skipping in SLK to generate an oncogenic ERK-activating isoform [#25], controlling tropomyosin splicing in cardiac muscle [#32], preventing intron retention in FOXO4 [#33], and supporting myelin gene (Mag, Nfasc) and histone-modifier (KDM6A, SIRT1) splicing programs that underlie oligodendrocyte differentiation and B cell activation [#21, #27]. In the cytoplasm it binds CA-repeat elements within target transcripts (MTNR1A, S100A9, WSB1, CCL5, CFTR) to stabilize them against exosome- and NMD-mediated decay, thereby tuning downstream signaling, ferroptosis, lipid metabolism, and immune chemoattraction [#13, #30, #23, #24]. On chromatin, HNRNPL acts as a transcriptional co-activator: it binds gene loci, recruits and stabilizes RNA polymerase II elongation, and forms phase-separated condensates that activate transcription of integrin/ECM genes in epidermal stem cells and PIK3CB in ovarian cancer [#15, #22]. This activity is frequently templated by non-coding RNAs—lncRNAs, enhancer RNAs, and promoter-derived transcripts (THRIL, seRNA-1, lncFAM, CASC8, SNHG1/6, circMGA)—that recruit or sequester HNRNPL at target promoters and modulate its stability and condensation [#0, #5, #20, #10, #22, #23]. It also delivers inactive P-TEFb (CDK9/CCNT2/HEXIM1/7SK) to promote Pol II elongation [#3] and serves as a structural adaptor bridging RNase-sensitive substructures of the Sam68 nuclear body via its RRMs [#4]. HNRNPL abundance is governed post-translationally by FBXO16-SCF-mediated ubiquitination and proteasomal degradation through its RRM3 domain [#9] and by SENP3-mediated deSUMOylation [#29]. Through these activities it is essential for B cell germinal-center responses, oligodendrocyte differentiation, epidermal stem cell maintenance, and spermatogenesis [#21, #27, #15, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"First evidence that hnRNP-L participates directly in transcriptional regulation rather than RNA processing alone, by complexing with APE1 at a promoter repressor element.\",\n      \"evidence\": \"EMSA, UV cross-linking, and co-IP on the nCaRE-B2 element of the APE1 promoter\",\n      \"pmids\": [\"11809897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protein-protein interaction shown but functional transcriptional output not measured genome-wide\", \"Single lab, single promoter context\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established hnRNP-L as a host RNA-binding factor that can be co-opted by viral replication complexes, binding HDV genomic RNA.\",\n      \"evidence\": \"UV cross-linking/MS, RNA affinity chromatography, and co-IP in HeLa cells\",\n      \"pmids\": [\"19464723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional perturbation of HDV replication shown\", \"RNA element binding characterized only in vitro\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed hnRNPL restrains genome mobility, acting as a negative regulator of LINE-1 retrotransposition through IRES RNA binding.\",\n      \"evidence\": \"RNA affinity chromatography, siRNA knockdown, and L1 retrotransposition reporter assay\",\n      \"pmids\": [\"23161687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which binding suppresses ORF2 translation/retrotransposition not resolved\", \"Endogenous L1 targets not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified hnRNPL as a regulator of spermatogenesis with opposing roles in germ versus Sertoli cells.\",\n      \"evidence\": \"2D-gel proteomics, MALDI-TOF, and siRNA knockdown in GC-1 and TM4 cells with target validation (CEACAM1, iNOS)\",\n      \"pmids\": [\"22245417\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct RNA targets versus indirect effects not distinguished\", \"Cell-type-specific opposing phenotype mechanism unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected hnRNPL to Pol II elongation control by showing it delivers inactive P-TEFb to target loci, linking it to the 7SK snRNP.\",\n      \"evidence\": \"Genome-scale shRNA screen, co-IP with CDK9/CCNT2/HEXIM1/7SK, flavopiridol-sensitivity, and in vivo KD\",\n      \"pmids\": [\"24434558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How hnRNPL selects elongation-dependent target genes unclear\", \"Direct versus 7SK-bridged interactions not fully dissected\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined a structural role for HNRNPL as an architectural adaptor bridging two RNase-sensitive substructures of the Sam68 nuclear body.\",\n      \"evidence\": \"Fluorescent cDNA screen of 32,651 clones, RNase treatment, systematic siRNA KD, and confocal imaging\",\n      \"pmids\": [\"27377249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the architectural RNAs bound by each RRM set not determined\", \"Function of the SNB itself remains unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"First lncRNA-templated transcriptional role: THRIL recruits hnRNPL to the TNF\\u03b1 promoter, establishing the recurring paradigm of ncRNA-guided HNRNPL chromatin recruitment.\",\n      \"evidence\": \"Reciprocal RIP, RNA pulldown, ChIP, and lentiviral KD with transcriptome analysis in macrophages\",\n      \"pmids\": [\"24371310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HNRNPL activates or represses depends on context not generalized here\", \"Mechanism of Pol II engagement at the promoter not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a pro-survival, oncogenic function in tumor cells through stabilization/binding of p53 and BCL-2 transcripts and sustained MAPK signaling.\",\n      \"evidence\": \"RIP, co-IP, siRNA/overexpression, and xenograft models in bladder and prostate cancer cells\",\n      \"pmids\": [\"28088793\", \"28038443\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect effects on p21/cyclin levels not separated\", \"RNA binding elements within targets not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Generalized HNRNPL as an enhancer-RNA-associated co-activator: seRNA-1 recruits it to drive Pol II and H3K36me3 deposition during myogenesis, with transcriptome-wide eRNA association.\",\n      \"evidence\": \"RIP, ChIRP, ChIP for Pol II/H3K36me3, and in vivo loss-of-function during myogenic differentiation\",\n      \"pmids\": [\"31857580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How eRNA binding mechanistically stabilizes Pol II not defined\", \"Selectivity of HNRNPL for specific enhancers unexplained\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated HNRNPL chromatin co-activator function is required for tissue homeostasis: it binds integrin/ECM gene loci, recruits Pol II, and maintains epidermal stem cells.\",\n      \"evidence\": \"ChIP, ChIP-seq, siRNA KD in keratinocytes, and conditional KO mouse epidermis with RNA-seq\",\n      \"pmids\": [\"34543262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether recruitment is RNA-dependent at these loci not tested\", \"Distinction from splicing-based contributions to phenotype incomplete\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established post-translational control of HNRNPL abundance via FBXO16-SCF ubiquitination targeting its RRM3 domain.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination assay, domain mapping, KO/rescue, and xenograft model\",\n      \"pmids\": [\"34333526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals triggering FBXO16-mediated degradation not identified\", \"Functional consequences for splicing/transcription targets not surveyed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined the cytoplasmic mRNA-stabilizing mechanism: HNRNPL binds CA-repeat coding-region elements to protect MTNR1A from EXOSC10-mediated decay.\",\n      \"evidence\": \"RNAi screen, RIP, mRNA stability assay, and KD/OE with downstream cAMP-CREB readout\",\n      \"pmids\": [\"32730662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HNRNPL antagonizes the exosome mechanistically not resolved\", \"Breadth of CA-repeat target transcriptome not mapped here\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed lncRNAs can both stabilize HNRNPL protein (CASC8 blocking polyubiquitination) and act as decoys to sequester it from mRNA targets (SNHG1, SNHG6), tuning its functional output.\",\n      \"evidence\": \"RNA pulldown, RIP, ubiquitination/co-IP assays, and rescue experiments in cancer models\",\n      \"pmids\": [\"35982900\", \"33542227\", \"34252487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Competition stoichiometry between decoy lncRNAs and mRNA targets not quantified\", \"Single-lab studies per lncRNA\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated splicing-program control underlies HNRNPL essentiality in B cell activation, regulating histone modifiers (KDM6A, SIRT1) and shaping global histone marks and mitochondrial function.\",\n      \"evidence\": \"Conditional KO mice, comparative RNA-seq across 8+ cell types, and H3K27me3/H3K9ac ChIP\",\n      \"pmids\": [\"38744970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct splicing targets versus downstream chromatin effects not fully separated\", \"Mechanism linking splicing changes to ROS not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended cytoplasmic mRNA stabilization to metabolic and immune outputs by stabilizing S100A9, WSB1, and CCL5 transcripts.\",\n      \"evidence\": \"RIP, RNA pulldown, actinomycin D decay assays, and rescue/xenograft models\",\n      \"pmids\": [\"38368714\", \"38822203\", \"36869127\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether all targets share the CA-repeat recognition mode not confirmed\", \"circMGA positive-feedback mechanism mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified an NMD-protective function: HNRNPL (with PTBP1) shields CFTR mRNA bearing nonsense alleles from decay.\",\n      \"evidence\": \"siRNA depletion and overexpression with quantitative mRNA decay measurement in 16HBE14o- cells across G542X/W1282X contexts\",\n      \"pmids\": [\"38045134\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding site on CFTR mRNA not mapped\", \"Mechanism of NMD antagonism not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established that HNRNPL forms chromatin phase-separated condensates that activate transcription, templated by a promoter-derived non-coding RNA at PIK3CB.\",\n      \"evidence\": \"ChIP, phase-separation assays, RIP, and CDX/PDO models with glycolysis measurement\",\n      \"pmids\": [\"40413189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domains driving condensation not mapped\", \"Generality of condensate-driven activation across loci not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected HNRNPL splicing activity to in vivo myelination via NMD-controlled levels and Mag/Nfasc splicing in oligodendrocytes.\",\n      \"evidence\": \"Conditional Smg5 KO in oligodendrocyte lineage, RNA-seq, splicing assays, EM of myelin, and motor testing\",\n      \"pmids\": [\"40930975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct splicing mechanism on Mag/Nfasc introns not biochemically detailed\", \"HNRNPL auto-regulation through NMD not fully traced\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Added a chromatin/DNA-repair role: an HNRNPL/CstF64-eRNA complex at the IgH 3'RR promotes Pol II elongation and NHEJ-mediated repair to govern class switch and locus suicide recombination.\",\n      \"evidence\": \"Co-IP, ChIP, eRNA transcription assays, CSR/LSR reporters, NHEJ assay, and 53BP1/Ku80 recruitment\",\n      \"pmids\": [\"40902003\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How HNRNPL facilitates 53BP1/Ku80 recruitment mechanistically unclear\", \"Direct versus eRNA-mediated contributions not separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified SENP3-mediated deSUMOylation as a second post-translational route controlling HNRNPL stability and a downstream Neat1-caspase-1 pyroptosis axis in liver injury.\",\n      \"evidence\": \"Co-IP, SUMOylation assay, and hepatocyte-specific SENP3 KO mice with Neat1/caspase-1 readout\",\n      \"pmids\": [\"40792025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SUMO acceptor sites on HNRNPL not mapped\", \"Link between SUMO status and Neat1 regulation not mechanistically resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HNRNPL's distinct activities—CA-rich splicing, cytoplasmic mRNA stabilization, ncRNA-guided chromatin co-activation, and condensate formation—are coordinated and selected within a given cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking RRM usage to functional partitioning\", \"Domain determinants of phase separation versus RNA binding undefined\", \"Rules governing which ncRNA recruits versus sequesters HNRNPL unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [2, 4, 5, 13, 25, 30, 33]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [25, 27, 33, 32]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 15, 22, 1]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [15, 22]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [11, 12]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 15, 22, 28, 33]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13, 30]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [15, 22, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [13, 24, 25, 27, 33]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 5, 15, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21, 23, 26]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [15, 16, 20, 27]}\n    ],\n    \"complexes\": [\"Sam68 nuclear body\", \"P-TEFb / 7SK snRNP-associated complex\", \"FBXO16-SCF E3 ligase complex\", \"hnRNPL/CstF64 eRNA complex\"],\n    \"partners\": [\"APE1\", \"CDK9\", \"CCNT2\", \"HEXIM1\", \"FBXO16\", \"SENP3\", \"CstF64\", \"PTBP1\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}